These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 20196276)
1. [Proportion of drug resistance among relapse tuberculosis cases --summary of Ryoken studies 1977-2002]. Yoshiyama T Kekkaku; 2009 Dec; 84(12):778-80. PubMed ID: 20196276 [No Abstract] [Full Text] [Related]
2. [Research and control of relapse tuberculosis cases]. Yamagishi F; Toyota M Kekkaku; 2009 Dec; 84(12):767-8. PubMed ID: 20077861 [TBL] [Abstract][Full Text] [Related]
3. Tuberculosis drug resistance: summary report for 2003. Can Commun Dis Rep; 2004 May; 30(10):93-5. PubMed ID: 15174496 [No Abstract] [Full Text] [Related]
4. [Current status of recurrence tuberculosis cases in Tokyo]. Nagamine M; Omori M; Maeda H; Furuya H Kekkaku; 2009 Dec; 84(12):772-4. PubMed ID: 20196272 [No Abstract] [Full Text] [Related]
5. [Sensitivity of Mycobacterium tuberculosis in our environment]. Unzaga MJ; Sota M; Melero P; Berdonces P; Ezpeleta C; Cisterna R Enferm Infecc Microbiol Clin; 1996; 14(6):399-400. PubMed ID: 8756225 [No Abstract] [Full Text] [Related]
6. [Comparative study of bactec MGIT 960 AST and conventional proportion method using Ogawa medium for the drug susceptibility testing of Mycobacterium tuberculosis to isoniazid]. Mitarai S; Kobayashi I; Abe C; Wada M; Suzuki K; Takashima T; Kawabe Y; Machida K; Tano M; Takigawa S; Kamada A; Shigetoh E; Fujii S; Mori K; Suyama H; Yano S; Kawashiro T; Ogata H Kekkaku; 2007 May; 82(5):449-54. PubMed ID: 17564123 [TBL] [Abstract][Full Text] [Related]
8. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance. Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897 [TBL] [Abstract][Full Text] [Related]
9. Further acquisition of drug-resistance in multidrug-resistant tuberculosis during chemotherapy. Toyota E; Sekiguchi J; Shimizu H; Fujino T; Otsuka Y; Yoshikura H; Kuratsuji T; Kirikae T; Kudo K Jpn J Infect Dis; 2004 Dec; 57(6):292-4. PubMed ID: 15623961 [No Abstract] [Full Text] [Related]
10. Children and multidrug-resistant tuberculosis in Mumbai (Bombay), India. Karande S; Bavdekar SB Emerg Infect Dis; 2002 Nov; 8(11):1360-1. PubMed ID: 12453371 [No Abstract] [Full Text] [Related]
11. Drug-resistant tuberculosis in Taipei, 1996-1999. Wang PD; Lin RS Am J Infect Control; 2001 Feb; 29(1):41-7. PubMed ID: 11172317 [TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes of Estonian patients with primary multidrug-resistant versus drug-susceptible tuberculosis. Lockman S; Kruuner A; Binkin N; Levina K; Wang Y; Danilovitsh M; Hoffner S; Tappero J Clin Infect Dis; 2001 Feb; 32(3):373-80. PubMed ID: 11170944 [TBL] [Abstract][Full Text] [Related]
13. High incidence of the Beijing genotype among multidrug-resistant isolates of Mycobacterium tuberculosis in a tertiary care center in Mumbai, India. Almeida D; Rodrigues C; Ashavaid TF; Lalvani A; Udwadia ZF; Mehta A Clin Infect Dis; 2005 Mar; 40(6):881-6. PubMed ID: 15736024 [TBL] [Abstract][Full Text] [Related]
14. Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis. Sacchettini JC; Rubin EJ; Freundlich JS Nat Rev Microbiol; 2008 Jan; 6(1):41-52. PubMed ID: 18079742 [TBL] [Abstract][Full Text] [Related]
15. Drug-resistance of Mycobacterium tuberculosis in time. Mazzei L; Croce GF; Zarzana A; Biagioli D; Sposato B; Pulcinelli A Eur Rev Med Pharmacol Sci; 1998; 2(1):21-4. PubMed ID: 9825566 [TBL] [Abstract][Full Text] [Related]
16. [Surveillance of resistance of Mycobacterium tuberculosis to anti-TB drugs in Cuba, 1995-1998]. Montoro E; Echemendía M; Lemus D; Marrero A; Llanes MJ; Valdivia JA Biomedica; 2004 Jun; 24 Supp 1():80-4. PubMed ID: 15495575 [TBL] [Abstract][Full Text] [Related]
17. [Detection of primary drug resistance rates of Mycobacterium tuberculosis complex strains isolated between 2002-2003 years and comparison with the data of 1998-2001 period]. Baylan O; Albay A; Kisa O; Tekbaş OF; Deniz O Mikrobiyol Bul; 2005 Apr; 39(2):153-60. PubMed ID: 16128025 [TBL] [Abstract][Full Text] [Related]
18. [Incidence of tuberculostatic-resistant Mycobacterium tuberculosis. Clinical aspects and impact on therapy and clinical course]. Esteban J; Gegúndez MI; García-Corbeira P; Soriano F Enferm Infecc Microbiol Clin; 1993 Oct; 11(8):415-9. PubMed ID: 8260512 [TBL] [Abstract][Full Text] [Related]
19. Development of acquired drug resistance in recurrent tuberculosis patients with various previous treatment outcomes. Yoshiyama T; Yanai H; Rhiengtong D; Palittapongarnpim P; Nampaisan O; Supawitkul S; Uthaivorawit W; Mori T Int J Tuberc Lung Dis; 2004 Jan; 8(1):31-8. PubMed ID: 14974743 [TBL] [Abstract][Full Text] [Related]
20. Trends in Mycobacterium tuberculosis resistance, Pakistan, 1990-2007. Hasan R; Jabeen K; Mehraj V; Zafar F; Malik F; Hassan Q; Azam I; Kadir MM Int J Infect Dis; 2009 Nov; 13(6):e377-82. PubMed ID: 19369103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]